Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-(-3-methoxy-5-methylpyrazin-2-yl)-2-(4-′1,3,4-oxadiazol-2-yl-phenyl)pyridine-3 sulphonamide as an anticancer agent

N-(-3-methoxy-5-methylpyrazin-2-yl)-2-(4-′1,3,4-oxadiazol-2-yl-phenyl)pyridine-3 sulphonamide as an anticancer agent

US Patent 7820679 · Granted Oct 26, 2010

Estimated economic value: $6,321,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic dendrimers2023
Therapeutic dendrimers2021
Therapeutic polymeric nanoparticles and methods of making and using same2020
Therapeutic dendrimers2019
Therapeutic polymeric nanoparticles and methods of making and using same2018
Binding proteins specific for insulin-like growth factors and uses thereof2017
Binding proteins specific for insulin-like growth factors and uses thereof2015
Methods of using insulin-like growth factor antibodies to treat tumors2013
Insulin-like growth factor antibodies and uses thereof2011
4-substituted quinolines as antitumor agents2009
Indolylalkylamino-methylidenecarbamate derivatives useful as GnRH antagonists2008
Substituted quinolines as antitumor agents2008